Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma

Abstract Background We wished to evaluate the efficacy and safety of liposomal paclitaxel and docetaxel for induction chemotherapy (IC) for nasopharyngeal carcinoma (NPC). Methods A total of 1498 patients with newly-diagnosed NPC between 2009 and 2017 treated with IC plus concurrent chemotherapy wer...

Full description

Bibliographic Details
Main Authors: Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Qiu-Yan Chen, Huan-Xin Lin, Yue-Feng Wen, Shan-Shan Guo, Li-Ting Liu, Hao-Jun Xie, Qing-Nan Tang, Yu-Jing Liang, Jin-Jie Yan, Chao Lin, Zhen-Chong Yang, Lin-Quan Tang, Ling Guo, Hai-Qiang Mai
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Subjects:
Nasopharyngeal carcinoma
Induction chemotherapy
Docetaxel
Liposomal paclitaxel
Online Access:http://link.springer.com/article/10.1186/s12885-018-5192-x

Internet

http://link.springer.com/article/10.1186/s12885-018-5192-x

Similar Items